Makoto Akimoto

Statistics

Publications

Citations

1.6K

H-Index

Active since

1991

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Mitsubishi Group (Japan)

Kyoto University

Makoto Akimoto is an author at Mitsubishi Tanabe Pharma Corporation specializing in neurodegenerative disease pharmacotherapy, life sciences, and edaravone therapy.

Publications per year

1991–2023

Publications

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

Life Sciences, Neurology, Neuroscience +11

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Koji Abe, Yasuto Itoyama, Gen Sobue et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2014 · 360 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Hypocholesterolemic Effect of Chitosan in Adult Males

Yuji Maezaki, Keisuke Tsuji, Yasue Nakagawa et al. · Bioscience Biotechnology and Biochemistry · 1993 · 240 citations

Life Sciences, Nutrition, Nutritional Sciences +13

Anti-Allergic Effect of Bryonolic Acid from<i>Luffa cylindrica</i>Cell Suspension Cultures

Shigeo Tanaka, Chikari Uno, Makoto Akimoto et al. · Planta Medica · 1991 · 40 citations

Life Sciences, Immunology, Pharmacology +13

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults

H. Shimizu, Yukiko Nishimura, Yoichi Shiide et al. · Clinical Pharmacology in Drug Development · 2021 · 34 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

1–5 of 8